A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver

I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of untreated experimental animals and increase with age. Additional I-compounds have now been observed in liver DNA of male Sprague-Dawley rats when t...

Full description

Saved in:
Bibliographic Details
Published inCarcinogenesis (New York) Vol. 9; no. 10; p. 1843
Main Authors Randerath, K, Lu, L J, Li, D
Format Journal Article
LanguageEnglish
Published England 01.10.1988
Subjects
Online AccessGet more information

Cover

Loading…
Abstract I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of untreated experimental animals and increase with age. Additional I-compounds have now been observed in liver DNA of male Sprague-Dawley rats when the chromatographic conditions were modified to allow for the detection of more polar adducts exhibiting low affinity to polyethyleneimine (PEI)--cellulose anion-exchange thin-layer material. The total I-compound level in 10-month-old animals was as high as one modification in approximately 10(7) nucleotides. This represented a minimum estimate since 100% recovery of all rat liver I-compounds in 32P-labeled form presumably was not achieved by the procedures used. The I-compound pattern was reproducible and variation of I-compound levels among individual animals of the same age was small. We have used regenerating rat liver herein as a model to compare the properties of I-compounds with those of persistent 2-acetylaminofluorene (AAF)-induced DNA adducts and of 5-methylcytosine (m5C), a normal enzymatic DNA modification. Eight- to 10-month-old male Sprague-Dawley rats were given 2-AAF (50 mg/kg in DMSO) or vehicle (DMSO) by i.p. injection. Partial hepatectomy was performed 6 weeks later (i.e. after AAF adduct levels had stabilized) and regenerating liver samples were taken 1 week after the operation for DNA analysis. Consistent with the restoration of cell and tissue loss, the overall levels of I-compounds and 2-AAF adducts were reduced to approximately 47% and approximately 45% respectively of control in regenerating liver by dilution with newly synthesized DNA, while the m5C level was not affected. Thus, in regenerating liver, I-compounds resembled carcinogen--DNA adducts and not m5C. This supports our hypothesis that the formation of these DNA modifications may be due to the binding to DNA of small amounts of reactive electrophilic by-products of normal metabolic activities, leading to the slow accumulation of I-compounds in tissue DNA with ageing.
AbstractList I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of untreated experimental animals and increase with age. Additional I-compounds have now been observed in liver DNA of male Sprague-Dawley rats when the chromatographic conditions were modified to allow for the detection of more polar adducts exhibiting low affinity to polyethyleneimine (PEI)--cellulose anion-exchange thin-layer material. The total I-compound level in 10-month-old animals was as high as one modification in approximately 10(7) nucleotides. This represented a minimum estimate since 100% recovery of all rat liver I-compounds in 32P-labeled form presumably was not achieved by the procedures used. The I-compound pattern was reproducible and variation of I-compound levels among individual animals of the same age was small. We have used regenerating rat liver herein as a model to compare the properties of I-compounds with those of persistent 2-acetylaminofluorene (AAF)-induced DNA adducts and of 5-methylcytosine (m5C), a normal enzymatic DNA modification. Eight- to 10-month-old male Sprague-Dawley rats were given 2-AAF (50 mg/kg in DMSO) or vehicle (DMSO) by i.p. injection. Partial hepatectomy was performed 6 weeks later (i.e. after AAF adduct levels had stabilized) and regenerating liver samples were taken 1 week after the operation for DNA analysis. Consistent with the restoration of cell and tissue loss, the overall levels of I-compounds and 2-AAF adducts were reduced to approximately 47% and approximately 45% respectively of control in regenerating liver by dilution with newly synthesized DNA, while the m5C level was not affected. Thus, in regenerating liver, I-compounds resembled carcinogen--DNA adducts and not m5C. This supports our hypothesis that the formation of these DNA modifications may be due to the binding to DNA of small amounts of reactive electrophilic by-products of normal metabolic activities, leading to the slow accumulation of I-compounds in tissue DNA with ageing.
Author Li, D
Lu, L J
Randerath, K
Author_xml – sequence: 1
  givenname: K
  surname: Randerath
  fullname: Randerath, K
  organization: Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030
– sequence: 2
  givenname: L J
  surname: Lu
  fullname: Lu, L J
– sequence: 3
  givenname: D
  surname: Li
  fullname: Li, D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/3168163$$D View this record in MEDLINE/PubMed
BookMark eNotkE1LAzEQhnOo1Fq9exFyVHDbTbJfOZb6VSh60XPJJpMa2U2WJK3sn_G3uksLA-_w8vAwzBWaWGcBoVuSLkjK2VIKL41d8sVYVBmboFlKMpYwxrJLdBXCT5qSguV8iqaMFNWwz9DfCkvXdsKb4CyuIf4CWKyM1uDBRhz7DgJ2eqCOohmbp_cVbt1AGCmicTbg-00yOtzBqvCIO_DBhDiip4vcfjAKpQ4yBiyswnnSQvzuG9lHF4yFB2ws9jBg4Ael3eMhcGOO4K_RhRZNgJtzztHXy_Pn-i3Zfrxu1qttIhmnMcmloppQwnRVMZWB5pLyEvJKpzXllNVQl3layFJkTJWFkJoVhJa6IlTycebo7uTtDnULatd50wrf785_ov_6B26b
CitedBy_id crossref_primary_10_1016_0165_1218_95_90001_2
crossref_primary_10_1016_S0027_5107_99_00009_3
crossref_primary_10_1093_jn_121_1_65
crossref_primary_10_1111_j_1440_1746_1990_tb01633_x
crossref_primary_10_1002__SICI_1098_2744_200001_27_1_34__AID_MC6_3_0_CO_2_G
crossref_primary_10_1016_0531_5565_95_02027_6
crossref_primary_10_1016_S1383_5742_97_00041_0
crossref_primary_10_1016_S0027_5107_98_00211_5
crossref_primary_10_1006_bbrc_1999_1528
crossref_primary_10_1111_j_1349_7006_1989_tb01722_x
crossref_primary_10_1016_0009_2797_94_03338_2
crossref_primary_10_1016_0531_5565_92_90008_N
crossref_primary_10_1016_0921_8734_89_90023_4
crossref_primary_10_1016_0009_2797_90_90101_R
crossref_primary_10_1016_0165_1110_90_90016_5
crossref_primary_10_1006_rtph_2000_1430
crossref_primary_10_1016_0041_008X_92_90117_B
crossref_primary_10_1016_0047_6374_91_90099_L
crossref_primary_10_1016_0300_483X_91_90075_C
crossref_primary_10_1016_0921_8734_90_90001_8
crossref_primary_10_1016_0300_483X_90_90167_F
crossref_primary_10_1016_S0027_5107_99_00018_4
crossref_primary_10_1016_0009_2797_92_90126_6
crossref_primary_10_1016_0009_2797_93_90090_L
crossref_primary_10_1016_0921_8734_93_90009_R
crossref_primary_10_1080_01635589209514189
crossref_primary_10_1016_0165_1218_95_90098_5
crossref_primary_10_1016_0921_8734_93_90024_W
crossref_primary_10_1016_0027_5107_91_90169_O
crossref_primary_10_1016_0921_8734_93_90007_P
crossref_primary_10_3109_03602539409029785
crossref_primary_10_1016_0027_5107_93_90077_S
crossref_primary_10_1007_BF00928150
crossref_primary_10_1016_0165_1161_93_90154_R
crossref_primary_10_1016_j_freeradbiomed_2004_05_024
crossref_primary_10_1016_0027_5107_91_90034_L
crossref_primary_10_1016_S0278_6915_96_00045_2
crossref_primary_10_1158_1055_9965_EPI_04_0759
crossref_primary_10_1002_em_2850160203
crossref_primary_10_1016_0921_8734_90_90028_P
crossref_primary_10_1016_0921_8734_92_90008_D
crossref_primary_10_1016_0165_1110_90_90020_C
crossref_primary_10_1016_0006_291X_92_91592_E
crossref_primary_10_1016_0304_3835_93_90076_L
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1093/carcin/9.10.1843
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 3168163
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R37-CA 32157
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.ZR
0R~
18M
1TH
29B
2WC
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
6J9
70D
A8Z
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWDT
ABEFU
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQTQ
ABSAR
ABSMQ
ABWST
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACMRT
ACNCT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACZBC
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFGWE
AFIYH
AFOFC
AFRAH
AFSHK
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APJGH
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASPBG
ATDFG
ATGXG
ATTQO
AVNTJ
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
BZKNY
C1A
C45
CAG
CDBKE
CGR
COF
CS3
CUY
CVF
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
ECM
EE~
EIF
EIHJH
EJD
ELUNK
EMOBN
ESTFP
F5P
F9B
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FRP
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
M49
MBLQV
MBTAY
N9A
NGC
NLBLG
NOMLY
NOYVH
NPM
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RHF
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
SV3
TCN
TEORI
TJX
TLC
TMA
TR2
W8F
WOQ
X7H
X7M
XOL
YAYTL
YKOAZ
YXANX
ZGI
ZKB
ZKX
ZXP
~91
ID FETCH-LOGICAL-c392t-5cd2f1213f883d4ef9c297e58f0b2923beb7506c7a43d76acf36127f812c92c92
ISSN 0143-3334
IngestDate Wed Oct 16 00:56:42 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c392t-5cd2f1213f883d4ef9c297e58f0b2923beb7506c7a43d76acf36127f812c92c92
PMID 3168163
ParticipantIDs pubmed_primary_3168163
PublicationCentury 1900
PublicationDate 1988-10-01
PublicationDateYYYYMMDD 1988-10-01
PublicationDate_xml – month: 10
  year: 1988
  text: 1988-10-01
  day: 01
PublicationDecade 1980
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Carcinogenesis (New York)
PublicationTitleAlternate Carcinogenesis
PublicationYear 1988
SSID ssj0016359
Score 1.582942
Snippet I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of...
SourceID pubmed
SourceType Index Database
StartPage 1843
SubjectTerms 2-Acetylaminofluorene - metabolism
5-Methylcytosine
Adenosine Triphosphate - metabolism
Animals
Body Weight
Cytosine - analogs & derivatives
Cytosine - analysis
DNA - metabolism
Liver - metabolism
Liver Regeneration
Male
Organ Size
Phosphorus Radioisotopes
Rats
Rats, Inbred Strains
Reference Values
Title A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver
URI https://www.ncbi.nlm.nih.gov/pubmed/3168163
Volume 9
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSxxBEG7WBIOXkIeSGJU65JCgrePOo2eOizFI0D0EBW_SzyDo7IKzB_0xXvyjqerunRkXQ0xgmVm6h57ero_a6uqvqhj7LNGEVfuJ5plylme5FlxSwkspCydzJarEkB_yZFwcnWU_zvPzweChx1qaNWpX3z0ZV_I_UsU2lCtFyf6DZNtBsQG_o3zxihLG67NkPIoUcl9GcM64mpc8abx79SbwxvGt1PJtPKLaN0QPihQ4MjA5jULllbxMp-RBQ9nj45oKDdUTfP82KqgZ8T7Iz55zqjt9e6Vvm8lNSFQawmJ--RzWnkiNt-0r4nz0rd-DdjxLeVAeFQJqHRI_fbyNDP6e1gl7PPMehO4U6_iy4yubEMZXli3_rXNkpjxNoyMzauKqD7ikp1apKM2T-j7kwgqrQVyPXWpceBhlNr32CKAiXfvF3zsXMnDHniW2JEpSpWNyCMWDKrTXqsCSDT8nnoTjvPbCrPbaOa2w5TjSwhbGmzKnb9jruAeBUQDUWzaw9Tv26iSyLN6z-xF0uIKIK2hxBR5XMHEwxxUgruARruBLD1U70GEKOkxBxBSgwGERU1_hsoY-ogBv4BG1ys6-H54eHPFYx4NrtL4bnmszdJQ60JVlajLrKj2shM1Ll6ghbjCUVWi3FlrILDWikNqlaHcLh7anruizxl7Uk9p-YGCNKpUuhbamyNRQVTLL8F9HpiYxRij1ka2Flb2YhmQtF3HJ1__U8YmtdPjcYC8d6ga7iYZmo7a8qH8DH02B6Q
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comparison+between+different+types+of+covalent+DNA+modifications+%28I-compounds%2C+persistent+carcinogen+adducts+and+5-methylcytosine%29+in+regenerating+rat+liver&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Randerath%2C+K&rft.au=Lu%2C+L+J&rft.au=Li%2C+D&rft.date=1988-10-01&rft.issn=0143-3334&rft.volume=9&rft.issue=10&rft.spage=1843&rft_id=info:doi/10.1093%2Fcarcin%2F9.10.1843&rft_id=info%3Apmid%2F3168163&rft_id=info%3Apmid%2F3168163&rft.externalDocID=3168163
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon